Women are less likely than men to receive drugs for multiple sclerosis (MS) between the ages of 18 to 40, during women's childbearing years, even when those drugs have been shown to be safe for use ...

Studies in a new meta-analysis show sex differences in average weight loss, but similar benefits across other sub-groups.

Women tended to lose more weight than men, meta-analysis shows ...

MINNEAPOLIS — Women are less likely than men to receive drugs for multiple sclerosis (MS) between the ages of 18 to 40, during women’s childbearing years, even when those drugs have been shown to be ...

Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among ...

A new study from the University of Bologna has raised questions about a widely used type of blood pressure medicine called beta‑blockers. These drugs have been prescribed for decades to lower blood ...

A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.